📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo. (2014)

First Author: Heap JT

Attributed to: Second Generation Sustainable Bacterial Biofuels funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.1761

PubMed Identifier: 24732092

Publication URI: http://europepmc.org/abstract/MED/24732092

Type: Journal Article/Review

Volume: 5

Parent Publication: Oncotarget

Issue: 7

ISSN: 1949-2553